Ispire Technology Reports Q3 2025 Financial Results

Ispire Technology, Inc. ( (ISPR) ) has released its Q3 earnings. Here is a breakdown of the information Ispire Technology, Inc. presented to its investors.

Ispire Technology Inc. is a company specializing in the research, development, and distribution of branded e-cigarettes and cannabis vaping products, operating primarily in the vaping technology sector with a focus on precision dosing.

In its fiscal third quarter of 2025, Ispire Technology Inc. reported a decrease in revenue and gross profit compared to the previous year, alongside strategic moves to streamline operations and enhance its market position.

The company recorded a revenue of $26.2 million, down from $30.0 million in the same quarter of the previous year, and a gross profit of $4.8 million, reflecting a decline in sales and gross margin. Despite these challenges, Ispire made significant operational changes, including transitioning manufacturing to Malaysia to mitigate geopolitical risks and reduce operating expenses by $8 million annually. Additionally, the company launched a new cannabis vapor device in collaboration with Raw Garden and filed a PMTA with the FDA for an innovative age-gating technology.

Ispire’s net loss widened to $10.9 million from $5.9 million in the previous year, largely due to increased operating expenses. However, the company successfully reduced its accounts receivable to $60.4 million, improving its financial stability and focusing on higher-quality customers.

Looking ahead, Ispire Technology Inc. remains committed to expanding its market presence and enhancing shareholder value through strategic initiatives, including securing a federal nicotine manufacturing license in Malaysia and continuing to innovate in vaping technology.